Trial Outcomes & Findings for Does Cap Assisted Colonoscopy Improve Detection of Adenomatous Polyps? (CAP Trial) (NCT NCT01935180)

NCT ID: NCT01935180

Last Updated: 2018-09-25

Results Overview

Mean number of adenomas per patient in each group.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

1148 participants

Primary outcome timeframe

duration of colonoscopy

Results posted on

2018-09-25

Participant Flow

Participant milestones

Participant milestones
Measure
Standard Colonoscopy
Standard colonoscopy without an attachment cap
Cap Assisted Colonoscopy
A transparent cap will be affixed to tip of the high-definition wide angle colonoscope. Colonoscopy Cap: 4mm transparent cap (Olympus) mounted to the tip of a colonoscope.
Overall Study
STARTED
573
575
Overall Study
COMPLETED
552
561
Overall Study
NOT COMPLETED
21
14

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Standard Colonoscopy
n=552 Participants
Standard colonoscopy without an attachment cap
Cap Assisted Colonoscopy
n=561 Participants
A transparent cap will be affixed to tip of the high-definition wide angle colonoscope. Colonoscopy Cap: 4mm transparent cap (Olympus) mounted to the tip of a colonoscope.
Total
n=1113 Participants
Total of all reporting groups
Age, Continuous
61.5 years
STANDARD_DEVIATION 8.4 • n=552 Participants
62.5 years
STANDARD_DEVIATION 8.3 • n=561 Participants
61.8 years
STANDARD_DEVIATION 8.3 • n=1113 Participants
Sex: Female, Male
Female
209 Participants
n=552 Participants
195 Participants
n=561 Participants
404 Participants
n=1113 Participants
Sex: Female, Male
Male
343 Participants
n=552 Participants
366 Participants
n=561 Participants
709 Participants
n=1113 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Region of Enrollment
United States
552 participants
n=552 Participants
561 participants
n=561 Participants
1113 participants
n=1113 Participants
Indication
Colonoscopy performed for cancer screening
291 Participants
n=552 Participants
292 Participants
n=561 Participants
583 Participants
n=1113 Participants
Indication
Colonoscopy performed for polyp surveillance
168 Participants
n=552 Participants
171 Participants
n=561 Participants
339 Participants
n=1113 Participants
Indication
Colonoscopy performed for symptoms (diagnostic)
93 Participants
n=552 Participants
98 Participants
n=561 Participants
191 Participants
n=1113 Participants

PRIMARY outcome

Timeframe: duration of colonoscopy

Mean number of adenomas per patient in each group.

Outcome measures

Outcome measures
Measure
Standard Colonoscopy
n=552 Participants
Colonoscopy without a cap.
Cap Assisted Colonoscopy
n=561 Participants
A transparent cap will be affixed to tip of the high-definition wide angle colonoscope.
Mean Number of Adenomas
0.82 adenoma per patient
Standard Deviation 1.5
0.89 adenoma per patient
Standard Deviation 1.6

SECONDARY outcome

Timeframe: duration of colonoscopy

• Adenoma detection rate (ADR), % of patients with at least 1 adenoma

Outcome measures

Outcome measures
Measure
Standard Colonoscopy
n=552 Participants
Colonoscopy without a cap.
Cap Assisted Colonoscopy
n=561 Participants
A transparent cap will be affixed to tip of the high-definition wide angle colonoscope.
Adenoma Detection Rate
219 Participants
235 Participants

SECONDARY outcome

Timeframe: duration of colonoscopy

Proportion of patients with advanced adenomas

Outcome measures

Outcome measures
Measure
Standard Colonoscopy
n=552 Participants
Colonoscopy without a cap.
Cap Assisted Colonoscopy
n=561 Participants
A transparent cap will be affixed to tip of the high-definition wide angle colonoscope.
Advanced Adenoma Detection Rate
49 Participants
55 Participants

SECONDARY outcome

Timeframe: duration of colonoscopy

Proportion of patients with a bowel preparation that was rated as good or excellent (four point scale that distinguishes the bowel prep as poor, fair, good or excellent).

Outcome measures

Outcome measures
Measure
Standard Colonoscopy
n=552 Participants
Colonoscopy without a cap.
Cap Assisted Colonoscopy
n=561 Participants
A transparent cap will be affixed to tip of the high-definition wide angle colonoscope.
Quality of Bowel Preparation
518 Participants
502 Participants

SECONDARY outcome

Timeframe: time of colonoscope withdrawal

• Time taken for the withdrawal of the colonoscope from the cecum to anus among patients, who did not have any polyps.

Outcome measures

Outcome measures
Measure
Standard Colonoscopy
n=552 Participants
Colonoscopy without a cap.
Cap Assisted Colonoscopy
n=561 Participants
A transparent cap will be affixed to tip of the high-definition wide angle colonoscope.
Withdrawal Time
8.9 minutes
Interval 7.4 to 11.2
8.4 minutes
Interval 6.7 to 10.2

SECONDARY outcome

Timeframe: during colonoscopy

• Proportion of patients, for whom intubation of the terminal ileum with the colonoscope was rated as "easy". Intubation could be rated by the endoscopist as "easy", "slightly difficult", "difficult", or "unable to intubate".

Outcome measures

Outcome measures
Measure
Standard Colonoscopy
n=552 Participants
Colonoscopy without a cap.
Cap Assisted Colonoscopy
n=561 Participants
A transparent cap will be affixed to tip of the high-definition wide angle colonoscope.
Ease of Terminal Ileum Intubation
435 Participants
473 Participants

SECONDARY outcome

Timeframe: duration of colonoscopy

Difference in recommended surveillance interval between real time polyp diagnosis and pathological diagnosis among patients with at least one diminutive polyp

Outcome measures

Outcome measures
Measure
Standard Colonoscopy
n=269 Participants
Colonoscopy without a cap.
Cap Assisted Colonoscopy
n=297 Participants
A transparent cap will be affixed to tip of the high-definition wide angle colonoscope.
Real Time Prediction of Polyp Histology
246 Participants
281 Participants

Adverse Events

Standard Colonoscopy

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Cap Assisted Colonoscopy

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Heiko Pohl

VA Medical Center

Phone: 8022959362

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place